Bhavana Acharya
Founding partner & Head – MFs and equities
About Bhavana
Bhavana was Deputy head of research at FundsIndia and was instrumental in converting many of the research outputs to products on the platform. She is a management graduate in finance with over 11 years of experience. 4 years were at FundsIndia, 7 years with The Hindu Business Line as research analyst.
Bhavana is an expert at analyzing stocks, sectors, and funds and creating portfolio products for investors. She is adept at providing structure and process to any research work and ensures a transparent and clear methodology to analysing products in an unbiased manner.
Bhavana’s ability to simplify complex analysis into simple, well-written, actionable commentaries has won the praise of many investors.
Bhavana is a management graduate from BIM.
Stay in touch
Bhavana in the media
- Why the carnage in mid and small cap stocks hit hybrid funds – Money Control
- Mutual funds bet on mid-caps cautiously – Economic Times
- Not so rewarding Credit card rewards – The Hindu Business Line
- Portfolio diversification – why and how – FundsIndia
- The lowdown on sector funds – FundsIndia
- It’s consumers to the rescue! – The Hindu Business Line
Watch Bhavana talk about her financial journey
Bhavana's recent articles
IPO Review : Zomato IPO – Invest or avoid?
If there’s talk in the stock markets today, it’s devoted to the upcoming Zomato IPO, which aims to mop up Rs 9,375 crore. Unlike the crop of recent private equity investor backed companies doing IPOs, this isn’t primarily an offer for sale. Zomato gets a whopping Rs 9,000 crore to deploy into its business mainly through a fresh issue of shares. Only one investor, Info Edge, will offload a Rs 375 crore stake. At the upper end of the price band of Rs 72-76, the post-offer market cap of listed Zomato will be around Rs 60,000 crore.
Understanding mutual fund performance – how to use ratios and other metrics
Rolling returns forms the base for several other ratios and metrics that are used frequently in understanding a fund’s performance. You know them – we talk about it when we write on funds, you see them in fund details pages. We are, of course, referring to the Sharpe ratio, alpha, beta, standard deviation and the like.
IPO review – KIMS Hospitals
KIMS Hospitals or Krishna Institute of Medical Sciences Hospital is a multi-speciality hospital chain with 9 centres, focused on the Andhra Pradesh-Telangana region. The KIMS Hospital IPO seeks to raise a sizeable Rs 2,143 crore (at the upper end of its price band of Rs 815-825). Of this, Rs 1943 crore is an offer for sale from PE investor General Atlantic, the promoters, and 44 other shareholders. The remaining will be used to pay off the already low borrowings and for general corporate purposes. Does the KIMS Hospital IPO make for a good long-term bet?
Prime Recommendation: 2 floating rate debt funds for medium time frames
With interest rates being where they are – i.e., stable with no clear signs of a move upwards or downwards – you would wonder where you could hold investments meant for a 2-3 year timeframe. And many of you also wonder if the best option you have is to go for floating rate debt funds as they would have an edge over other debt fund categories.
When is it fine to make lumpsum investments?
If there’s one thing all mutual fund investors are clear about, it’s that SIPs are a great thing. Every time you have money to invest, it is not a given that you use SIPs (or STPs). There are times when it’s perfectly fine to be making lumpsum investments.
Prime Recommendation: Mid-cap returns with would-be bluechips
There’s another index that gives mid and small-cap funds a good run for their money while housing far bigger names. This is a high return index if highly volatile one, and can be used in long-term portfolios to give returns a boost.